Valuation: GC Corp.

Market Cap 443B 331M 298M 276M 249M 471M 31.04B 483M 3.3B 1.32B 16.62B 1.24B 1.22B 52.9B P/E 2024
33.1x
P/E 2025 -10.5x
Enterprise Value 1,837B 1.37B 1.24B 1.14B 1.03B 1.96B 129B 2B 13.7B 5.46B 68.96B 5.15B 5.04B 219B EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
43.96%
Yield 2024
2.89%
Yield 2025 1.88%
1 day-0.92%
1 week+3.41%
Current month+6.13%
1 month-0.51%
3 months-8.75%
6 months-28.15%
Current year-39.07%
1 week 9,200
Extreme 9200
9,950
1 month 8,940
Extreme 8940
9,950
Current year 8,630
Extreme 8630
18,010
1 year 8,630
Extreme 8630
18,010
3 years 8,630
Extreme 8630
18,490
5 years 8,630
Extreme 8630
29,400
10 years 8,630
Extreme 8630
56,300
Manager TitleAgeSince
Chief Executive Officer 52 28/02/2010
Chief Executive Officer 72 24/03/2010
Corporate Officer/Principal 43 -
Director TitleAgeSince
Chairman 72 16/12/2010
Director/Board Member 76 28/02/2009
Director/Board Member 52 28/02/2010
Date Insider Type Main position Quantity % Market Cap. Importance
25/04/25 Buy

Chief Executive Officer

1,334 0.0028%
25/04/25 Buy

Chief Executive Officer

3,191 0.0068%
25/04/25 Buy

Chief Executive Officer

6,748 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.92%+3.41%-39.94%-33.88% 332M
-0.13%+0.86%+44.66%+133.41% 1,276B
-0.17%+1.39%+44.54%+89.77% 676B
+0.02%-0.39%+30.43%+111.84% 519B
+0.02%+1.52%+39.21%+68.34% 388B
-0.95%-2.63%+60.98%+42.88% 365B
-1.29%-1.13%+27.54%+56.87% 307B
+0.09%-0.91%+3.19%+35.60% 287B
+0.31%-2.53%+37.80%+74.87% 252B
-0.65%-2.75%+38.45%+126.45% 212B
Average -0.38%+2.11%+28.69%+70.61% 428B
Weighted average by Cap. -0.26%+2.51%+39.09%+94.45%

Financials

2024 2025
Net sales 2,205B 1.65B 1.49B 1.37B 1.24B 2.35B 155B 2.4B 16.45B 6.55B 82.78B 6.18B 6.05B 263B 2,451B 1.83B 1.65B 1.53B 1.38B 2.61B 172B 2.67B 18.29B 7.29B 92.04B 6.88B 6.73B 293B
Net income 24.03B 17.96M 16.18M 14.95M 13.52M 25.57M 1.68B 26.2M 179M 71.42M 902M 67.39M 65.96M 2.87B -69.51B -51.96M -46.83M -43.26M -39.11M -73.99M -4.87B -75.82M -518M -207M -2.61B -195M -191M -8.31B
Net Debt 1,042B 779M 702M 649M 586M 1.11B 73.05B 1.14B 7.77B 3.1B 39.12B 2.92B 2.86B 125B 1,394B 1.04B 939M 868M 784M 1.48B 97.72B 1.52B 10.4B 4.14B 52.34B 3.91B 3.83B 167B
Projected Income Statement - Annual - GC Corp.
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
142
Date Price Change Volume
10/11/26 ₩9,700.00 -0.92% 84,435
10/11/26 ₩9,790.00 +4.04% 66,470
09/11/26 ₩9,410.00 -0.63% 76,724
06/11/26 ₩9,470.00 -2.27% 92,438
05/11/26 ₩9,690.00 +1.47% 91,451
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock